Raymond James Financial’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$248	Buy	+200	New	+$248	﹤0.01%	6672